|
Thursday, 24 October 2019 |
|
 |
|
Timing |
Title |
Speaker |
Slides |
09:00/09:20 |
SRS for Trigeminal Neuralgia and Epilepsy |
Pantaleo Romanelli (Milan, Italy) |
 |
09:20/09:40 |
SRS for Optic Pathways and Skull Base |
Alfredo Conti (Messina, Italy) |
 |
09:40/10:00 |
SRS for Acoustic Schwannomas |
Alexander Muacevic (Munich, Germany) |
 |
10:00 /10:20 |
SRS for Gliomas |
Scott Soltys (Stanford, California, USA) |
 |
10:20/10:40 |
Brain Metastases |
Maximilian Ruge (Cologne, Germany) |
 |
11:15/13:00 |
BRAIN AND SPINE SRS ORAL ABSTRACT PRESENTATIONS |
|
|
11:15/11:25 |
Factors affecting Outcome in Frameless Non-Isocentric Stereotactic
Radiosurgery for Trigeminal Neuralgia: A Multicentric Cohort Study |
Alfredo Conti, MD, PhD, University Of Messina, Italy |
 |
|
|
|
|
11:35/11:45 |
Gamma Knife Radiosurgery for Arteriovenous Malformations: A Clinical Series
of 199 Patients |
Selcuk Peker, MD, Koc University School of Medicine, Istanbul, Turkey |
 |
11:45/11:55 |
Safety of Cyberknife Radiosurgery in Optic Nerve Sheath Meningioma |
Carolin Senger, MD, Charité University Hospital Berlin, Germany |
 |
12:05/12:50 |
BRAIN AND SPINE SRS ORAL ABSTRACT PRESENTATIONS |
|
|
12:05/12:10 |
Preliminary Results of Fractionated Cyberknife Radiosurgery for Uveal
Melanoma |
Isa Bossi Zanetti, MD, Centro Diagnostico Italiano, Italy |
 |
12:10/12:15 |
Longitudinal Radiographic Outcomes of Vestibular Schwannoma in Single and
Fractionated Stereotactic Radiosurgery |
Mohamed Khattab, MD, Vanderbilt University Medical Center, TN, USA |
 |
12:15/12:20 |
A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single
and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma |
Mohamed Khattab, MD, Vanderbilt University Medical Center, TN, USA |
 |
12:20/12:25 |
Analysis of the Efficacy of Gamma Knife in Treating Primary Trigeminal
Neuralgia |
Zhoushuang Sun, MD, Friendship Hospital, People’s Republic of China |
 |
12:25/12:30 |
Efficacy and Safety of Cyberknife Radiosurgery in Elderly with Brain Metastases |
Güliz Acker, Charité University Hospital, Germany |
 |
12:30/12:35 |
Hypofractionated Stereotactic Radiosurgery (hSRS) as Salvage Treatment of
Brain Metastases |
Daniel Rueß, MD, University Hospital of Cologne, Germany |
 |
12:40/12:45 |
The Combined Stereotactic Radiosurgery and Endovascular Approach for Large
Arteriovenous Malformations |
Vladyslav Buryk, MD, PhD, Sigulda Hospital, Latvia |
 |
12:45/12:50 |
Gamma Knife Anterior Capsulotomy for Treatment Resistant Obsessive
Compulsive Disease |
Selcuk Peker, MD, Koc University School of Medicine, Istanbul, Turkey |
 |
14:00/16:00 |
STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR EXTRACRANIAL LESIONS |
|
|
14:00/14:20 |
SBRT for Oligometastatic Disease |
Shalom Kalnicki (New York, USA) |
 |
14:20/14:40 |
Stereotactic Radiosurgery for Spinal Lesions |
Madhur K. Garg (New York, USA) |
 |
14:40/15:00 |
SBRT for Lung Cancer |
Hale Basak Caglar (Anadolu, Turkey) |
 |
15:00/15:20 |
SBRT fro Hepatobilliary Tumors |
Andrew Gaya (London, UK) |
 |
15:20/15:40 |
SBRT for Primary Renal Cell Carcinoma |
Alexander Muacevic (Munich, Germany) |
 |
15:40/16:00 |
SBRT for Prostate Cancer |
Giancarlo Beltramo (Milan, Italy) |
 |
16:00/16:20 |
NRG/SWOG Clinical Trials for Prostate Stereotactic Radiation Therapy: Issues
and Questions |
Richard K. Valicenti, (California, USA) |
 |
16:30 /18:00 |
SBRT FOR EXTRACRANIAL LESIONS ORAL ABSTRACTS |
|
|
16:30/16:40 |
Cost-Effectiveness Analysis of Upfront SBRT for Oligometastatic Stage IV Non/Small Cell Lung Cancer Based on Mutational Status |
Diane Ling, MD, University of Pittsburgh Medical Center Hillman Cancer
Center, PA, USA |
 |
16:40/16:50 |
Stereotactic Body Radiotherapy (SBRT) for Metastasic Abdomino-Pelvic Lymph
Nodes |
Paula Antonini, MD, Hospital Virgen del Consuelo, Spain |
 |
16:50/17:00 |
Plan Quality and Treatment Time of Patients Receiving Pancreatic SBRT with
Volumetric Modulated Arc Therapy |
Rojymon Jacob, MD, University of Alabama at Birmingham, AL, USA |
 |
17:00/17:10 |
Evaluation of Outcomes after Stereotactic Hypofractionated Radiotherapy for
Prostate Cancer |
Giancarlo Beltramo, MD, Centro Diagnostico Italiano, Milan, Italy |
 |
17:10/17:15 |
Stereotactic Robotic Body Radiotherapy for Carcinoma Prostate |
Tejinder Kataria nee Sethi, MD, Medanta Cancer Institute, The Medicity, India |
 |
17:15/17:20 |
Evaluation of SABR (Stereotactic Ablative Body Radiotherapy) in the
Management of Oligometastatic Prostate Cancer: A Case Report of Single
Center |
Maris Mezeckis, MD, Sigulda Hospital, Latvia
Vladyslav Buryk, MD, PhD, Sigulda Hospital, Latvia |
 |
17:20 /17:25 |
Hypofractionated Robotic Radiosurgery for Relapsed and Oligometastatic
Prostate Cancer |
Bora Uysal, MD, University of Health Sciences, Gulhane Training and Research
Hospital, Ankara, Turkey
Azamat Dauletkazin MD, University of Health Sciences, Kutahya Training and
Research Hospital, Kutahya, Turkey
Hakan Gamsiz, MD, University of Health Sciences, Gulhane Training and
Research Hospital, Ankara, Turkey
Omer Sager, MD, University of Health Sciences, Gulhane Training and Research
Hospital, Ankara, Turkey
Ferrat Dincoglan, MD, University of Health Sciences, Gulhane Training and
Research Hospital, Ankara, Turkey
Selcuk Demiral, MD, University of Health Sciences, Gulhane Training and
Research Hospital, Ankara, Turkey
Murat Beyzadeoglu, MD, University of Health Sciences, Gulhane Training and
Research Hospital, Ankara, Turkey |
 |
17:25/17:30 |
SBRT to Portal Vein Tumor Thrombus: Paving the Way for Liver Transplant |
Shyam Singh Bisht, MD, Medanta-The Medicity, India |
 |